Papers
1
Total Citations
18
H-Index
1
About
M. Zanazzi is a leading researcher in nephrology and urological oncology, with a focused expertise in renal functional outcomes following surgical interventions. Their most significant contribution lies in pioneering novel biomarkers for the early detection of acute kidney injury (AKI) and, crucially, for predicting long-term kidney function decline after partial nephrectomy. In their highly cited 2023 work (18 citations), Zanazzi moved beyond traditional serum creatinine monitoring by systematically comparing the predictive power of kineticGFR, cystatin C, and neutrophil gelatinase-associated lipocalin. This research provided clinicians with a vital framework for identifying patients at risk of chronic eGFR deterioration immediately post-surgery, enabling earlier, more personalized nephroprotective strategies. By bridging the gap between acute perioperative events and chronic renal outcomes, Zanazzi’s work has directly impacted surgical decision-making and long-term patient management in kidney cancer care. Their findings are increasingly referenced in guidelines for nephron-sparing surgery, marking them as a key voice in the effort to preserve long-term renal health in oncology patients.
Research Focus
Key Achievements
Top Papers
- 1